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It has been well established that platelets are associated
with tumor progression and metastasis as they can support
angiogenesis and prevent hemorrhage. As such, platelets
may be an ideal target for enhancing anticancer immu-
notherapies. Thus, we hypothesized that inducing throm-
bocytopenia would increase the leakiness of tumor
vasculature thereby facilitating the effective delivery of
antigen-specific T cells generated by DNA vaccination to
tumor loci in order to induce CD8+ T cell-mediated
tumor killing. We have previously developed a therapeutic
HPV DNA vaccine encoding calreticulin (CRT) linked to
HPV-16 E7 antigen (CRT/E7) to enhance therapeutic
DNA vaccine potency. In the current study, we explore
the employment of a platelet-depleting antibody or
heparin in combination with CRT/E7 DNA vaccine in
a mouse model for its potential to enhance E7-specific
CD8+ T cell immune responses as well as antitumor
effects against E7-expressing tumors. We induced severe
acute thrombocytopenia in mice bearing subcutaneous
TC-1 tumors. TC-1 tumor cells originate from the mouse
lung and express the HPV-16 E7 tumor-specific antigen.
In a TC-1 mouse tumor model, platelet depletion
increased E7-specific CD8+ T cells in the peripheral blood
and reduced the growth of the tumor mass following
CRT/E7 DNA vaccination. Next, we isolated platelet-rich
plasma from tumor-bearing and naïve mice. When TC-1
tumor cells were coincubated with E7-specific CD8+ T
cells under platelet-rich plasma and found that E7-specific
CD8+ T cells had decreased IFN-g secretion in the
presence of platelet-rich plasma from tumor-bearing mice
compared to that of naïve mice. Furthermore, when
incubated with E7-specific CD8+ T cells and platelets,
TC-1 cells were killed significantly less efficiently com-
pared to those incubated with E7-specific CD8+ T cells
alone. Importantly, we found that GFP-tagged TC-1 cells
incubated with platelets were coated by the platelets,
which were subsequently activated (CD26P+). Taken
together, these data suggest that platelet depletion
increases tumor-specific CD8+ T cells and enhances their
tumor killing effects. Furthermore, This study provides
proof in principle that platelets directly inhibit CD8+
T cells from killing tumor cells. In conclusion, platelet
depletion or heparin therapy can stimulate antitumor
immune responses and this treatment methodology may
be applicable to a variety of cancers.
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